Details
Title
Outcome measures of phase III anticancer drug trials in China
Author
Guo Lanwei 1 ; Huang Huiyao 2 ; Yu, Yue 2 ; Wang, Jun 3 ; Wang, Le 4 ; Wang Shuhang 2 ; Wu, Dawei 2 ; Yuan, Fang 2 ; Jiang, Ning 2 ; Zhang Shaokai 1 ; Tang, Yu 2 ; Li, Ning 2
1 Department of Cancer Epidemiology and Prevention, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan 450008, China
2 Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
3 National Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China
4 Department of Cancer Prevention, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang 310022, China
1 Department of Cancer Epidemiology and Prevention, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan 450008, China
2 Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
3 National Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China
4 Department of Cancer Prevention, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang 310022, China
Pages
992-994
Section
Correspondence
Publication year
2023
Publication date
Apr 2023
ISSN
03666999
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2813966208
Copyright
Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.